AU2001274315A1 - Transcutaneous prosthesis - Google Patents
Transcutaneous prosthesisInfo
- Publication number
- AU2001274315A1 AU2001274315A1 AU2001274315A AU2001274315A AU2001274315A1 AU 2001274315 A1 AU2001274315 A1 AU 2001274315A1 AU 2001274315 A AU2001274315 A AU 2001274315A AU 2001274315 A AU2001274315 A AU 2001274315A AU 2001274315 A1 AU2001274315 A1 AU 2001274315A1
- Authority
- AU
- Australia
- Prior art keywords
- component
- prosthesis
- prosthesis according
- bone
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
TRANSCUTANEOUS PROSTHESIS
This invention relates to transcutaneous prosthesis and includes a method of fitting a prosthesis having a transcutaneous component to a patient.
Amputation of limbs or digits can occur due to trauma or because of surgical removal. Examples of trauma include loss of fingers in machinery accidents, loss of limbs in car accidents or as a result of land mine explosions. Surgical removal can also be indicated as a result of cardio-vascular disease, diabetes and cancerous tumours to the bone or soft tissues.
After amputation, it is common to fit an external endo-prosthetic device that is attached to the body via by a skin interface. This commonly involves the manufacture of a custom-made socket which is secured to the stump using straps or clamps. A number of disadvantages arise from the use of such endo-prosthetic devices. For example:-
(1) Skin is not a satisfactory high load bearing structure and often breaks down under load, becoming inflamed and uncomfortable and, in severe cases, pressure sores are formed which are difficult to heal.
(2) Changes in the shape of the stump may mean that a new custom-made socket is required.
(3) The use of sockets for receiving the stump are commonly sweaty and uncomfortable.
(4) "Where a joint is involved, the external prosthesis is usually moved by muscle groups situated at a distance from the attached prosthesis and therefore motion is inefficient and unnatural.
A major object of the present invention is to provide a prosthesis which overcomes some or all of the above disadvantages.
According to one aspect of the present invention there is provided a transcutaneous prosthesis which comprises a first component shaped for implantation into a bone, a second component intended for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell
proliferation and attachment of epithelial cells and a third component intended for location exterior to the skin surface having a low surface energy which deters bacterial adhesion.
The prosthesis provided by the present invention is thus an intra-osseous transcutaneous prosthesis (ITAP) and has a number of advantages. For example, the first component is attached directly to load-bearing parts of the bony skeleton such that load is transmitted through bone. This means that the patient is able to apply much more power to the prosthesis. Also, motion and perception of movement is more natural because of the bone attachment. Moreover, because the skin takes no part in transmitting the load from the bone to the external part of the prosthesis, there is no pressure on the skin surface which would cause inflammation or discomfort.
The first component is formed with some suitable means for preventing rotation of the component in the bone which may comprise flutes or grooves or functionally similar shaped surfaces. These surfaces may be shaped to fit the profile of the intramedullary cavity, where present. Also, the first component is preferably provided with a surface treatment which encourages osseous integration. Suitable surface treatments include hydroxyapatite which is a hydrated calcium phosphate. The surface may also be formed with small apertures or pits to encourage integration between the bone and the first component. Where micro pits are formed in the surface, these may be of the order of 20 to 500 microns in size, preferably 20 to 100 microns.
The second component extends between the bone and the epithelial surface. This component is provided with a surface treatment for stimulating fibrous tissue ingrowth. Again, this component may be treated with an hydroxyapatite or aluminium oxide coating and the coating treated with materials which encourage the adhesion of epithelial cells to the second component. This component may also have a coating which is porous to encourage soft tissue ingrowth. Materials which encourage such growth include adhesion promoting proteins such as fibronectin or laminin. In order to aid adhesion of the fibrous tissue to the second component, the hypodermis is
preferably surgically removed during the procedure of installing the prosthesis. The goal is to attach the skin to the implant to prevent movement of the skin and shear forces separating epithelial cells at the interface and underlying dermis and thereby permitting infection to enter between the skin and the prosthesis.
The third component comprises the exterior part of the prosthesis and this has a low surface energy which deters bacterial adhesion. A low surface energy can be achieved by coating this part of the prosthesis with a non-stick material such as a diamond-like carbon, a fluorinated polymer or a silicone polymer.
The prosthesis may be made up from separate components connected together, or two or more of the components may be formed integrally and given appropriate surface treatments.
The external component will preferably include a safety device comprising a linkage which breaks under an unusual load such as, for example, one caused by the patient falling. This will allow the external component to detach from the skeletal and transcutaneous component without causing damage to the bone or to the skin. An additional feature which will protect the fixation of an intramedullary post is an external device which limits torque transmitted to the adjustable fixation. The torque transmitted may be adjustable so that with time, the transmitted torque can be increased, as the internal component integrates with the bone.
In a further preferred embodiment of the present invention the second component may be provided so as to extend outwardly from the first and third components in a manner that increases the external surface area of the second component. The second component may also be provided with through holes which -further increase the external surface area and allow growth of tissue through the second component. This has been found to advantageously facilitate the integration of the component with fibrous tissue growttu
The invention is illustrated by the accompanying drawings in which: -
Figures 1 and 2 are diagrammatic views through part of a deer's antler and skull;
Figure 3 is a diagrammatic part section showing a transcutaneous prosthesis in accordance with the invention, fitted to a patient.
Figure 4 is a perspective view of a preferred embodiment of a prosthesis in accordance with the present invention drawn on a larger scale compared with Figure 3.
Referring to the drawings, the present invention was in part stimulated by study of the skin-bone interface around red "deer antlers. This is a unique structure and may be thought of as a biological model for a transcutaneous implant. The deer antler at periods of the year is very heavily loaded during the rut. Histological examination indicates that the layer of skin epithelial cells become thinner as the epithelial layer approaches the antler, such that at the antler-skin interface an epithelial skin layer is only about one cell thick. The dermis is intimately attached to the bone (pedicle) interface. The attachment is achieved through a series of "Sharpeys fibres" which attach to the dermis and to the bone and prevent differential skin movement. Antlers do not normally become infected and the bone structure is invaginated with small pores measuring 18 to 40 microns in diameter. This helps the interface between the dermis and the bone to resist shear stresses. These features are shown in Figures 1 and 2 of the accompanying drawings.
The prosthesis of the present invention is shown in Figure 3 and may be considered an artificial analogue of the deer's antler. The prosthesis comprises a first component (1) which is inserted into the intramedullary canal of a bone (2). Component (1) is formed with longitudinally extending cutting flutes which engage in the bone as the prosthesis is inserted into the intramedullary canal and resists rotation. The surface of the component (1) may be coated with a material to encourage osseous integration such as a hydroxy apatite material and/or be micro-pitted. The second component (4) extends from the end of the bone to the surface of the skin. This component may be cylindrical as drawn, or could be flattened to a mushroom shape, thereby increasing the surface area over which the soft tissue can be attached. Component (4) is given a surface treatment to encourage attachment of the epithelial to the implant. Such surface treatments include giving the surface a micro-pitted
structure and/or coating the surface with adhesion proteins such as laminin or fibronectin which encourage fibrous growth into the surface of the component (4) of the prosthesis.
Prior to installing the prosthesis, the hypodermis is preferably surgically removed. Further, a surface is provided on the second component which is porous and promotes fibrous tissue ingrowth. Suitable materials for coating the surface include alumina oxide ceramics and hydroxy apatite. This surface, preferably after being given a porous surface treatment, is coated with an adhesion promoting protein, e.g. by spraying the prosthesis with a solution of the adhesion-promoting protein, by dipping the prosthesis in a concentrated solution of the protein and freeze drying, or by dipping into a sterile solution of the adhesion-promoting protein prior to implantation.
The removal of the hypodermis surgically during the amputation and installation procedure assists in stimulating attachment of the skin to the implant and thereby prevents shear forces on the skin separating the epithelial cells at the interface.
The third component (5) of the prosthesis extends through the skin and is given a non-stick surface on its exterior portion. Suitable materials include fluorinated polymers such as polytetrafluoroethylene, siliconised polymers and diamond like carbon. The presence of a non-stick surface discourages bacteria from attaching to the prosthesis and helps to prevent infection. The non-stick surface may be applied to the exterior portion of the third component (5) using the technique of chemical vapour deposition (CVD). The use of CND is well known in the art for applying a surface of diamond-like carbon. When applying a surface layer of diamond, as disclosed in EP- B-0545 542 the method generally involves providing a mixture of hydrogen or oxygen gas and a suitable gaseous carbon compound such as a hydrocarbon, applying energy to that gas to dissociate the hydrogen into atomic hydrogen or the oxygen into atomic oxygen and the carbon into active carbon ions, atoms or CH radicals and allowing such active species to deposit on the substrate to form diamond. The energy to cause dissociation may be provided in a number of ways common to the art, for example by hot filament or by microwave source. A non-stick surface of fluorinated polymer or
silicone polymer may be applied to the third component by polymerising a monomer or prepolymer in contact with the component.
It may be convenient to apply the low energy surface treatment to the third component while masking the remaining components of the prosthesis. Also, the second component of the prosthesis may be treated with the adhesion-promoting protein after applying the low energy surface to the third component, and it may be desirable to mask the third component while applying the adhesion-promoting protein.
The third component may be connected to an artificial limb or digit. For example, in the case of a replacement finger or part finger, the first component may be implanted into the rernaining bone with the second component instituting the transcutaneous portion, and the third component extending beyond the severed stump. An artificial digit or part digit can then be attached to the third component.
The prosthesis may be implanted either in a one-stage procedure or in a two- stage procedure where the first component is implanted into the bone and allowed to integrate before the transcutaneous part is attached.
There is shown in figure 4 a -further preferred embodiment of the present invention wherein the second component (4) is extended in an outward direction perpendicular to the first and third components in a plate like form. This feature provides the second component (4) with a large surface area which advantageously facilitates the integration of the second component (4) with fibrous tissue growth. As also shown in Figure 4, through holes (6) may be provided in the plate like extension of the second component (4), which further increase the external surface area and also allowing tissue to grow through the second component further facilitating integration. Although the above description refers to a series of components, it will be appreciated that each component may be a portion of an integral element manufactured from a single piece of material. It is, however, preferred that a frangible linkage is provided between the third and second components or between the second and first component, so that in the event that a high load is applied to the third component, or to a member attached thereto, the linkage will fair so as to protect the implanted bone from injury.
While the present invention has been described with particular reference to the provision of a prosthesis for replacement of lost digits or limbs, the invention is also applicable to other prosthesis which extend through the skin, e.g. dental implants.
Claims (11)
1. A transcutaneous prosthesis which comprises a first component shaped for implantation into a bone, a second component intended for location between the bone and the skin, the second component having a surface treatment for stimulation of fibroblastic cell proliferation and attachment of epithelial cells and a third component intended for location exterior to the skin surface having a low surface energy which deters bacterial adhesion.
2. A prosthesis according to claim 1 wherein the components are integrally formed and have different surface treatments.
3. A prosthesis according to claim 1 or 2 wherein the first component has a surface treatment which stimulates bone growth and osseous integration.
4. A prosthesis according to any one of the preceding claims wherein the second component has a micro-pitted surface.
5. A prosthesis according to any one of the preceding claims wherein the surface of the second component carries a fibronectin or laminin coating.
6. A prosthesis according to any one of the preceding claims wherein the second component extends outwardly from the first and third components.
7. A prosthesis according to claim 6 wherein the second component has through holes.
8. A prosthesis according to any one of the preceding claims where the third component carries a coating comprising a fluoro- or silicone polymer.
9. A prosthesis according to any one of the preceding claims wherein the third component carries a coating comprising diamond like carbon.
10. A prosthesis according to any one of the preceding claims wherein the third component includes a frangible or detachable linkage which permits an external component to detach in the event that an unusually high load is applied to the prosthesis.
11. A prosthesis according to any one of the preceding claims in which the third component is connected to an artificial limb or digit.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0015479.9A GB0015479D0 (en) | 2000-06-23 | 2000-06-23 | Transcutaneous Prosthesis |
GB0015479.9 | 2000-06-23 | ||
PCT/GB2001/002771 WO2001097718A1 (en) | 2000-06-23 | 2001-06-22 | Transcutaneous prosthesis |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001274315A1 true AU2001274315A1 (en) | 2002-03-21 |
AU2001274315B2 AU2001274315B2 (en) | 2006-02-16 |
Family
ID=9894311
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001274315A Expired AU2001274315B2 (en) | 2000-06-23 | 2001-06-22 | Transcutaneous prosthesis |
AU7431501A Pending AU7431501A (en) | 2000-06-23 | 2001-06-22 | Transcutaneous prosthesis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU7431501A Pending AU7431501A (en) | 2000-06-23 | 2001-06-22 | Transcutaneous prosthesis |
Country Status (23)
Country | Link |
---|---|
US (5) | US7014661B2 (en) |
EP (1) | EP1292248B1 (en) |
JP (1) | JP2003535643A (en) |
KR (1) | KR100800631B1 (en) |
CN (1) | CN1236736C (en) |
AT (1) | ATE341291T1 (en) |
AU (2) | AU2001274315B2 (en) |
BG (1) | BG64965B1 (en) |
BR (1) | BR0111903B1 (en) |
CA (1) | CA2411095C (en) |
CZ (1) | CZ20024159A3 (en) |
DE (1) | DE60123606T2 (en) |
DK (1) | DK1292248T3 (en) |
ES (1) | ES2273847T3 (en) |
GB (2) | GB0015479D0 (en) |
IL (2) | IL152995A0 (en) |
MX (1) | MXPA02012218A (en) |
NZ (1) | NZ523131A (en) |
PL (1) | PL195416B1 (en) |
RU (2) | RU2288673C2 (en) |
WO (1) | WO2001097718A1 (en) |
YU (1) | YU97402A (en) |
ZA (1) | ZA200209308B (en) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR876M (en) | 1960-10-12 | 1961-10-16 | ||
US20040006396A1 (en) * | 1993-11-02 | 2004-01-08 | Ricci John L. | Transcutaneous devices having nueral interface |
GB0215916D0 (en) | 2002-07-10 | 2002-08-21 | Univ Dundee | Coatings |
DE10302432B4 (en) * | 2003-01-17 | 2005-01-05 | Eska Implants Gmbh & Co. | finger prosthesis |
DE10357579B4 (en) * | 2003-12-08 | 2006-01-26 | Otto Bock Healthcare Gmbh | Implant with a skin passage section |
GB2411841B (en) | 2004-03-12 | 2006-08-09 | Univ London | Prosthetic limb attachment |
WO2005115259A2 (en) * | 2004-05-24 | 2005-12-08 | Biomedical Strategies | Wound closure system and methods |
BE1016116A4 (en) * | 2004-07-09 | 2006-03-07 | Cubber Jan De | MODULAR FRAME WITH COSMETIC COVER TO REPLACE THE FINGERBOT STRUCTURE. |
US20060041318A1 (en) * | 2004-08-19 | 2006-02-23 | Shannon Donald T | Laminar skin-bone fixation transcutaneous implant and method for use thereof |
DE102004055623A1 (en) * | 2004-11-11 | 2006-05-24 | Eska Implants Gmbh & Co. | Subcutaneous, intramuscular bearing for a rigid transcutaneous implant |
US8414907B2 (en) * | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
US9119901B2 (en) * | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
WO2007013948A2 (en) * | 2005-07-20 | 2007-02-01 | University Of Utah Research Foundation | Antimicrobial containment cap for a bone anchored prosthesis mounting system |
US8257435B2 (en) * | 2005-09-23 | 2012-09-04 | Mark Pitkin | Skin integrated device |
US20070162150A1 (en) * | 2006-01-12 | 2007-07-12 | Fago John R | Modular prosthetic implant for upper and lower extremity amputees |
US8197930B1 (en) | 2007-05-10 | 2012-06-12 | Hrl Laboratories, Llc | Three-dimensional ordered open-cellular structures |
US8287895B1 (en) * | 2008-04-24 | 2012-10-16 | Hrl Laboratories, Llc | Three-dimensional biological scaffold compromising polymer waveguides |
US7909883B2 (en) * | 2007-02-21 | 2011-03-22 | Sidebotham Christopher G | Percutaneous implant for limb salvage |
SE531177C2 (en) | 2007-05-24 | 2009-01-13 | Cochlear Ltd | Distance for implants |
FR2930423B1 (en) * | 2008-04-25 | 2010-05-07 | Gerard Scortecci | DEVICE FOR BONE REGENERATION |
GB0905009D0 (en) * | 2009-03-24 | 2009-05-06 | Stanmore Implants Worldwide Ltd | Percutaneous device |
US20110093014A1 (en) * | 2009-10-19 | 2011-04-21 | Zimmer Spine, Inc. | Rod with Removable End and Inserter Therefor |
US8512416B2 (en) | 2010-02-01 | 2013-08-20 | Biomet Manufacturing, Llc | Transdermal intraosseous device |
JP6046709B2 (en) * | 2011-06-06 | 2016-12-21 | ユニヴァーシティ オブ ユタ リサーチ ファンデーション | Percutaneous osteosynthesis prosthetic implant system |
US9433505B2 (en) | 2011-06-06 | 2016-09-06 | University Of Utah Research Foundation | Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesis |
US9539773B2 (en) | 2011-12-06 | 2017-01-10 | Hrl Laboratories, Llc | Net-shape structure with micro-truss core |
US8968415B2 (en) | 2012-02-07 | 2015-03-03 | Biomet Manufacturing, Llc | Implant fixation device |
US9017806B2 (en) | 2012-03-23 | 2015-04-28 | Hrl Laboratories, Llc | High airflow micro-truss structural apparatus |
GB201205993D0 (en) | 2012-04-03 | 2012-05-16 | Ucl Business Plc | Control of prosthetic devices |
DE102012015483B3 (en) * | 2012-08-07 | 2014-01-16 | Otto Bock Healthcare Gmbh | Electrode arrangement for a plasma treatment and device for producing a transcutaneous connection |
WO2014040061A1 (en) * | 2012-09-10 | 2014-03-13 | Ortho Transmission, Llc | Transcutaneous implant for skeletal attachment of external prosthetic devices |
GB2507327A (en) * | 2012-10-26 | 2014-04-30 | Fitzbionics Ltd | Percutaneous implant for attaching exoprosthesis |
DE102012021003B4 (en) | 2012-10-26 | 2015-02-12 | Otto Bock Healthcare Products Gmbh | Percutaneous implant and method of making such an implant |
US9023115B2 (en) | 2013-01-31 | 2015-05-05 | Biomet Manufacturing, Llc | Transdermal intraosseous device |
US8915970B2 (en) | 2013-02-08 | 2014-12-23 | Biomet Manufacturing, Llc | Transdermal prosthesis |
AU2015200026B2 (en) * | 2014-02-14 | 2016-05-19 | Longo, Joseph A. | Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesis |
ES2869075T3 (en) | 2014-04-16 | 2021-10-22 | Osseointegration Holdings Pty Ltd | An osseointegrable device |
US9844451B2 (en) | 2014-04-25 | 2017-12-19 | Biomet Manufacturing, Llc | Modular transdermal compress device |
WO2015200266A1 (en) * | 2014-06-23 | 2015-12-30 | Community Blood Center | Cellular-scale surface modification for increased osteogenic protein expression |
US20150374503A1 (en) * | 2014-06-30 | 2015-12-31 | Bacterin International, Inc. | Implant for fusion between adjacent bone bodies |
US10039651B2 (en) | 2015-01-14 | 2018-08-07 | Carnegie Mellon University, A Pennsylvania Non-Profit Corporation | Microminiature chainmail interface between skin and a transcutaneous prosthetic device and a method of manufacture |
CN106618816A (en) * | 2016-11-22 | 2017-05-10 | 中国人民解放军第四军医大学 | Novel prosthetic limb connecting device |
CN106510818B (en) * | 2016-11-22 | 2019-08-23 | 中国人民解放军第四军医大学 | A kind of modular construction improving external fixator for orthopedics dep percutaneously sealing effect |
US10537661B2 (en) | 2017-03-28 | 2020-01-21 | DePuy Synthes Products, Inc. | Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same |
US10537658B2 (en) | 2017-03-28 | 2020-01-21 | DePuy Synthes Products, Inc. | Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same |
EP3808308A4 (en) * | 2018-06-15 | 2022-01-26 | Narayama Limited Liability Company | Method of producing a dental implant using a composite nanocoating |
RU186732U1 (en) * | 2018-09-10 | 2019-01-30 | Сергей Сергеевич Горшков | OSTEO-INTEGRATED LIMB PROSTHESIS |
RU2695623C1 (en) * | 2018-09-10 | 2019-07-24 | Сергей Сергеевич Горшков | Method for osteointegrated prosthesis implantation |
RU206864U1 (en) * | 2021-05-26 | 2021-09-30 | федеральное государственное бюджетное образовательное учреждение высшего образования «Донской государственный технический университет» (ДГТУ) | Veterinary osseointegrated implant |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947897A (en) | 1975-03-17 | 1976-04-06 | Owens Lester J | Apparatus for connecting a prosthesis to a bone |
US4143426A (en) | 1977-03-30 | 1979-03-13 | The United States Of America As Represented By The Administrator Of Veterans Affairs | Permanently attached artificial limb |
US4158895A (en) | 1978-02-09 | 1979-06-26 | Nasa | Prosthesis coupling |
SE416175B (en) * | 1979-03-07 | 1980-12-08 | Per Ingvar Branemark | FOR IMPLANTATION IN BODY TISSUE Separate Bone Tissue, Dedicated Material |
US4549319A (en) * | 1982-08-03 | 1985-10-29 | United States Medical Corporation | Artificial joint fixation to bone |
CA1247960A (en) | 1983-03-24 | 1989-01-03 | Hideki Aoki | Transcutaneously implantable element |
DE3316801A1 (en) | 1983-05-07 | 1984-11-08 | Friedrichsfeld Gmbh, Steinzeug- Und Kunststoffwerke, 6800 Mannheim | SEMI-IMPLANT |
DE3439993C2 (en) * | 1984-11-02 | 1986-12-04 | Friedrichsfeld GmbH Keramik- und Kunststoffwerke, 6800 Mannheim | Implant for supplying amputation stumps |
JPS61200903A (en) | 1985-03-04 | 1986-09-05 | Akihisa Segawa | Material to be embedded in living body |
SU1454438A1 (en) | 1985-11-10 | 1989-01-30 | Каунасский Медицинский Институт | Tooth implant |
JPH0655219B2 (en) | 1986-03-04 | 1994-07-27 | 住友セメント株式会社 | Artificial limb attachment |
JPS6455730A (en) | 1987-08-27 | 1989-03-02 | Matsushita Electric Ind Co Ltd | Magnetic recording medium |
KR890701070A (en) | 1987-11-09 | 1989-12-19 | 원본미기재 | Implantation method of prosthetic device |
AU5154390A (en) * | 1989-02-15 | 1990-09-05 | Microtek Medical, Inc. | Biocompatible material and prosthesis |
US5169597A (en) * | 1989-12-21 | 1992-12-08 | Davidson James A | Biocompatible low modulus titanium alloy for medical implants |
JPH04183463A (en) | 1990-11-16 | 1992-06-30 | Tdk Corp | Artificial tooth root |
GB9123331D0 (en) | 1991-11-04 | 1991-12-18 | De Beers Ind Diamond | Apparatus for depositing a material on a substrate by chemical vapour deposition |
JPH05155730A (en) | 1991-12-03 | 1993-06-22 | Nippon Oil & Fats Co Ltd | Dental coating agent |
EP0547354A1 (en) | 1991-12-17 | 1993-06-23 | Dr.Ing.h.c. F. Porsche Aktiengesellschaft | Adjustable hip joint endoprothesis |
DE9400720U1 (en) | 1994-01-18 | 1995-05-18 | Schreiber, Hans, Dr. Dr., 68167 Mannheim | Stump prosthesis |
US5725573A (en) * | 1994-03-29 | 1998-03-10 | Southwest Research Institute | Medical implants made of metal alloys bearing cohesive diamond like carbon coatings |
US5501706A (en) * | 1994-11-29 | 1996-03-26 | Wildflower Communications, Inc. | Medical implant structure and method for using the same |
DE19504386C2 (en) * | 1995-02-10 | 1997-08-28 | Univ Dresden Tech | Process for the production of a graded coating from calcium phosphate phases and metal oxide phases on metallic implants |
RU2163246C2 (en) | 1995-06-30 | 2001-02-20 | Коммонвелт Сайентифик Энд Индастриал Рисерч Организейшн | Method of modifying at least part of polymer surface |
US5709683A (en) * | 1995-12-19 | 1998-01-20 | Spine-Tech, Inc. | Interbody bone implant having conjoining stabilization features for bony fusion |
EP2105138A3 (en) * | 1996-04-19 | 2013-06-05 | Osiris Therapeutics, Inc. | Regeneration and augmentation of bone using mesenchymal stem cells |
EP0806212B1 (en) * | 1996-05-10 | 2003-04-02 | IsoTis N.V. | Device for incorporation and release of biologically active agents |
AU708593B2 (en) | 1996-06-03 | 1999-08-05 | Mathys Medizinaltechnik Ag | Femur component for a hip endoprosthesis |
US5981827A (en) | 1996-11-12 | 1999-11-09 | Regents Of The University Of California | Carbon based prosthetic devices |
DE19826638C2 (en) * | 1998-06-17 | 2000-07-06 | Eska Implants Gmbh & Co | Adapter for an exoprosthetic standard part |
JP4183463B2 (en) | 2002-09-19 | 2008-11-19 | 三井化学株式会社 | Amorphous alloy ribbon laminate and method for producing the same |
-
2000
- 2000-06-23 GB GBGB0015479.9A patent/GB0015479D0/en not_active Ceased
-
2001
- 2001-06-22 MX MXPA02012218A patent/MXPA02012218A/en active IP Right Grant
- 2001-06-22 AU AU2001274315A patent/AU2001274315B2/en not_active Expired
- 2001-06-22 KR KR1020027015755A patent/KR100800631B1/en active IP Right Grant
- 2001-06-22 RU RU2003101908/14A patent/RU2288673C2/en active
- 2001-06-22 WO PCT/GB2001/002771 patent/WO2001097718A1/en active IP Right Grant
- 2001-06-22 YU YU97402A patent/YU97402A/en unknown
- 2001-06-22 EP EP01940821A patent/EP1292248B1/en not_active Expired - Lifetime
- 2001-06-22 AU AU7431501A patent/AU7431501A/en active Pending
- 2001-06-22 DE DE60123606T patent/DE60123606T2/en not_active Expired - Lifetime
- 2001-06-22 JP JP2002503196A patent/JP2003535643A/en active Pending
- 2001-06-22 DK DK01940821T patent/DK1292248T3/en active
- 2001-06-22 CN CNB018115195A patent/CN1236736C/en not_active Expired - Lifetime
- 2001-06-22 CA CA002411095A patent/CA2411095C/en not_active Expired - Lifetime
- 2001-06-22 PL PL01359159A patent/PL195416B1/en not_active IP Right Cessation
- 2001-06-22 BR BRPI0111903-6A patent/BR0111903B1/en not_active IP Right Cessation
- 2001-06-22 NZ NZ523131A patent/NZ523131A/en not_active IP Right Cessation
- 2001-06-22 IL IL15299501A patent/IL152995A0/en active IP Right Grant
- 2001-06-22 CZ CZ20024159A patent/CZ20024159A3/en unknown
- 2001-06-22 GB GB0115381A patent/GB2365355B/en not_active Expired - Lifetime
- 2001-06-22 ES ES01940821T patent/ES2273847T3/en not_active Expired - Lifetime
- 2001-06-22 AT AT01940821T patent/ATE341291T1/en not_active IP Right Cessation
- 2001-06-22 US US10/311,589 patent/US7014661B2/en not_active Expired - Lifetime
-
2002
- 2002-11-15 ZA ZA200209308A patent/ZA200209308B/en unknown
- 2002-11-21 IL IL152995A patent/IL152995A/en unknown
- 2002-11-25 BG BG107317A patent/BG64965B1/en unknown
-
2006
- 2006-01-03 US US11/306,584 patent/US8628584B2/en not_active Expired - Lifetime
- 2006-03-20 RU RU2006108631/14A patent/RU2406466C2/en active
-
2008
- 2008-10-09 US US12/248,091 patent/US20090149966A1/en not_active Abandoned
-
2010
- 2010-09-13 US US12/880,867 patent/US8137409B2/en not_active Expired - Fee Related
-
2013
- 2013-12-19 US US14/134,106 patent/US9452066B2/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1292248B1 (en) | Transcutaneous prosthesis | |
AU2001274315A1 (en) | Transcutaneous prosthesis | |
US10835392B2 (en) | Transdermal intraosseous device | |
US8078282B2 (en) | Implantable tissue growth stimulator | |
Tolman et al. | Extraoral application of osseointegrated implants | |
AU2015246643C1 (en) | An osseointegrable device | |
Pitkin | On the way to total integration of prosthetic pylon with residuum | |
US8877499B2 (en) | Bone anchor | |
Chizoba | ROBOHUMAN: THE PRESENCE AND FUTURE OF MODERN MEDICINE |